… In contrast, PR status for the primary tumor rather than PR status at relapse seems to have
an impact on patient survival. Interestingly, the intraindividual ER groups reflect a trend of …

… patients were recruited in this study. The correlation between estrogen receptor (ER)/progesterone …
and the survival rate was assessed after 5-year follow-up. Results: The 5-year overall …

… p53 expression, presence of estrogen and progesterone receptors on survival were evaluated.
… Contrary to the current literature, our findings suggest that estrogen and progesterone …

… In the PP data set, multivariate analyses confirmed that both ER and PgR are independent
significant predictors of disease-free and overall survival among patients who received …

… Furthermore, and perhaps even more important, we have now shown that the ER- patients
have significantly worse survival than the ER+ group.* These data have been recently …

… , and patient gender significantly correlate with PR status. Although gender alone was not
a significant factor in patient survival, there was a higher proportion of male patients in the …

… with receptor-positive primary tumors, a hypothesis that is supported by the observation in
the present study that survival after relapse was longer for receptorpositive patients. Similar …

… to a shorter disease free survival (p = 0.027), while the ratio of PR-A/PR-B < 1 both was
associated with a shorter disease free survival as well as a shorter overall survival (p = 0.044 and …

… Based on analysis of survival curves of OC patients, it was possible to determine the ER and
… We have found that 5year survival of 75.0% and 65.0% was reliably higher in OC patients …

… To test the prognostic value of PR in breast cancer patients, we assessed the survival …
patient survival and determining hormone therapy strategies, beyond that obtained by estrogen …